In patients with PLA2R-positive malignancy-associated MN, serum PLA2R antibody IgG subtypes were found to be consistent with those of primary MN (10, 46), suggesting that the pathogenesis of PLA2R-positive malignancy-associated MN and PLA2R-positive primary MN may have pathways in common. This evidence concerns the gene PLA2R1 and cancer.